論文

査読有り
2017年10月

Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinoma

CANCER CELL INTERNATIONAL
  • Takehiro Hayashi
  • ,
  • Taro Yamashita
  • ,
  • Hikari Okada
  • ,
  • Kouki Nio
  • ,
  • Yasumasa Hara
  • ,
  • Yoshimoto Nomura
  • ,
  • Tomoyuki Hayashi
  • ,
  • Yoshiro Asahina
  • ,
  • Mariko Yoshida
  • ,
  • Naoki Oishi
  • ,
  • Hajime Sunagozaka
  • ,
  • Hajime Takatori
  • ,
  • Masao Honda
  • ,
  • Shuichi Kaneko

17
開始ページ
94
終了ページ
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1186/s12935-017-0467-x
出版者・発行元
BIOMED CENTRAL LTD

Background: The relationship between specific genome alterations and hepatocellular carcinoma (HCC) cancer stem cells (CSCs) remains unclear. In this study, we evaluated the relationship between somatic mutations and epithelial cell adhesion molecule positive (EpCAM(+)) CSCs.
Methods: Two patient-derived HCC samples (HCC1 and HCC2) were sorted by EpCAM expression and analyzed by whole exome sequence. We measured PCDH18 expression level in eight HCC cell lines as well as HCC1 and HCC2 by real-time quantitative RT-PCR. We validated the identified gene mutations in 57 paired of HCC and matched non-cancerous liver tissues by Sanger sequence.
Results: Whole exome sequencing on the sorted EpCAM(+) and EpCAM(-) HCC1 and HCC2 cells revealed 19,263 nonsynonymous mutations in the cording region. We selected mutations that potentially impair the function of the encoded protein. Ultimately, 60 mutations including 13 novel nonsense and frameshift mutations were identified. Among them, PCDH18 mutation was more frequently detected in sorted EpCAM(+) cells than in EpCAM(-) cells in HCC1 by whole exome sequences. However, we could not confirm the difference of PCDH18 mutation frequency between sorted EpCAM(+) and EpCAM(-) cells by Sanger sequencing, indicating that PCDH18 mutation could not explain intracellular heterogeneity. In contrast, we found novel PCDH18 mutations, including c.2556_2557delTG, c.1474C > G, c.2337A > G, and c.2976G > T, were detected in HCC1 and 3/57 (5.3%) additional HCC surgical specimens. All four HCCs with PCDH18 mutations were EpCAM-positive, suggesting that PCDH18 somatic mutations might explain the intertumor heterogeneity of HCCs in terms of the expression status of EpCAM. Furthermore, EpCAM-positive cell lines (Huh1, Huh7, HepG2, and Hep3B) had lower PCDH18 expression than EpCAM-negative cell lines (PLC/PRL/5, HLE, HLF, and SK-Hep-1), and PCDH18 knockdown in HCC2 cells slightly enhanced cell proliferation.
Conclusions: Our data suggest that PCDH18 is functionally suppressed in a subset of EpCAM-positive HCCs through somatic mutations, and may play a role in the development of EpCAM-positive HCCs.

Web of Science ® 被引用回数 : 2

リンク情報
DOI
https://doi.org/10.1186/s12935-017-0467-x
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/29075151
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000413644700001&DestApp=WOS_CPL

エクスポート
BibTeX RIS